Exploring U-M’s Opportunities Around the World

 

Newsroom

PCSK9 & Cardiovascular Disease Risk

November 5, 2019
Written by

Variation in serum PCSK9, cardiovascular disease risk and potential unanticipated effects of PCSK9 inhibition: A GWAS and Mendelian randomization study in the HUNT study, Norway.


Browse news by region: